Anthracycline induced cardiotoxicity
Clinical trials for Anthracycline induced cardiotoxicity explained in plain language.
Never miss a new study
Get alerted when new Anthracycline induced cardiotoxicity trials appear
Sign up with your email to follow new studies for Anthracycline induced cardiotoxicity, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New trial aims to shield hearts from chemo side effects
Prevention Not yet recruitingThis study tests whether a drug called sotagliflozin can prevent heart, muscle, and fat damage caused by a common type of chemotherapy (anthracycline) in people with newly diagnosed lymphoma. About 60 adults who are scheduled to receive high-dose anthracycline will take either th…
Matched conditions: ANTHRACYCLINE INDUCED CARDIOTOXICITY
Phase 2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
Heart shield: statin may guard against chemo damage in breast cancer
Prevention Not yet recruitingThis study tests whether taking rosuvastatin, a cholesterol-lowering drug, can prevent heart damage caused by anthracycline chemotherapy in women with breast cancer. Four hundred participants will receive either rosuvastatin or a placebo daily for 12 months. The main goal is to s…
Matched conditions: ANTHRACYCLINE INDUCED CARDIOTOXICITY
Phase 4 • Sponsor: Shiraz University of Medical Sciences • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC